Drugs & Targets Dignity Health, Catholic Health Initiatives Launch Precision Medicine Alliance September 23, 2016Vol.42 No.35
Drugs & Targets ORIEN and HudsonAlpha announce new research collaboration September 23, 2016Vol.42 No.35
Drugs & Targets St. Jude Children’s Research Hospital and Wellcome Trust Sanger Institute agree to exchange cancer mutation data September 23, 2016Vol.42 No.35
Drugs & Targets Golden Meditech and MD Anderson announce creation of Cellenkos Inc. September 23, 2016Vol.42 No.35
Drugs & Targets EMA recommends conditional marketing authorization for olaratumab September 23, 2016Vol.42 No.35
Drugs & Targets Novartis, MEI Pharma. Receive Breakthrough Therapy Designations September 22, 2016Vol.39 No.08
Drugs & Targets Amgen acquires rights from Boehringer Ingelheim for BI 836908 (AMG 420) September 09, 2016Vol.42 No.33
Drugs & Targets Regeneron Pharmaceuticals and Adicet Bio to develop next-gen engineered immune cell therapeutics September 09, 2016Vol.42 No.33
Drugs & Targets Palmetto GBA issues final local coverage determination for ProMark September 09, 2016Vol.42 No.33
Drugs & Targets BTG International Canada receives approval from Health Canada for DC Bead LUMI September 09, 2016Vol.42 No.33
